CMS issued a proposed rule that would revise certain aspects of the Medicare Advantage (MA) program (Part C), the Prescription Drug Benefit program (Part D); implement certain provisions of the Bipartisan Budget Act of 2018; improve quality and accessibility; clarify certain program integrity
Read more →